0000929638-24-002002.txt : 20240529 0000929638-24-002002.hdr.sgml : 20240529 20240529181254 ACCESSION NUMBER: 0000929638-24-002002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glickman Richard M CENTRAL INDEX KEY: 0001352637 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41854 FILM NUMBER: 241000062 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: enGene Holdings Inc. CENTRAL INDEX KEY: 0001980845 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 BUSINESS PHONE: (514) 332-4888 MAIL ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 4 1 form4.xml X0508 4 2024-05-28 0001980845 enGene Holdings Inc. ENGN 0001352637 Glickman Richard M C/O 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 QUEBEC, CANADA true false Common Shares 2024-05-28 4 M 0 120 0.89 A 24675 D Stock Option (Right to Buy) 0.89 2024-05-28 4 M 0 120 0 D Common Shares 120 0 D This option is fully vested and exercisable. This option was originally due to expire December 4, 2023, however prior to that date the expiration date was extended to 120 days following the filing of enGene Holdings Inc.'s Form S-8, which was filed February 27, 2024. Accordingly, the option expiry date is June 26, 2024. /s/ Richard M. Glickman 2024-05-29